Score Overview
Explore the 2021 public Archive ranking →
Where Laboratory Corporation of America Holdings has ranked, year by year
Showing 10 years ranking history by HDB Score.
Reached the top 50 on HDB Score in 3 years, the longest run being 2 in a row — but not in 2021.
- LH
2001: 77.1% · 2021: 21.0% · free through 2021 · longest runs
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-11-17 | $ 368.24 | — |
1 Year2025-11-17 | $ 258.75 | 42.31% |
5 Years2021-11-17 | $ 236.04 | 56.01% |
10 Years2016-11-17 | $ 103.56 | 255.57% |
20 Years2006-11-17 | $ 56.70 | 6x |
30 Years1996-11-15 | $ 6.62 | 55x |
All Time1990-03-29 | $ 19.89 | 18x |
| Period | Last Price2026-11-17 | 1 Year2025-11-17 | 5 Years2021-11-17 | 10 Years2016-11-17 | 20 Years2006-11-17 | 30 Years1996-11-15 | All Time1990-03-29 |
|---|---|---|---|---|---|---|---|
| Price | $ 368.24 | $ 258.75 | $ 236.04 | $ 103.56 | $ 56.70 | $ 6.62 | $ 19.89 |
| Return | — | 42.31% | 56.01% | 255.57% | 6x | 55x | 18x |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
Reported in USD
| Year | |||
|---|---|---|---|
| TTM | $ 14.59B | $ 1.00B | $ 261M |
| 2025 | $ 13.95B | $ 876M | $ 532M |
| 2024 | $ 13.00B | $ 746M | $ 1.51B |
| 2023 | $ 12.16B | $ 418M | $ 536M |
| 2022 | $ 11.86B | $ 1.27B | $ 320M |
| 2021 | $ 13.13B | $ 2.37B | $ 1.47B |
| 2020 | $ 13.97B | $ 1.55B | $ 1.32B |
| 2019 | $ 11.55B | $ 823M | $ 337M |
| 2018 | $ 11.33B | $ 883M | $ 426M |
| 2017 | $ 10.44B | $ 1.26B | $ 316M |
| 2016 | $ 9.64B | $ 732M | $ 433M |
| 2015 | $ 8.68B | $ 436M | $ 716M |
| 2014 | $ 6.01B | $ 511M | $ 580M |
| 2013 | $ 5.80B | $ 573M | $ 404M |
| 2012 | $ 5.67B | $ 583M | $ 466M |
| 2011 | $ 5.54B | $ 519M | $ 159M |
| 2010 | $ 5.00B | $ 558M | $ 230M |
| 2009 | $ 4.69B | $ 543M | $ 148M |
| 2008 | $ 4.50B | $ 464M | $ 219M |
| 2007 | $ 4.06B | $ 476M | $ 166M |
| 2006 | $ 3.59B | $ 431M | $ 186M |
| 2005 | $ 3.32B | $ 386M | $ 63M |
| 2004 | $ 3.08B | $ 363M | $ 206M |
| 2003 | $ 2.93B | $ 321M | $ 123M |
| 2002 | $ 2.50B | $ 254M | $ 56M |
| 2001 | $ 2.19B | $ 179M | $ 149M |
| 2000 | $ 1.91B | $ 112M | $ 48M |
| 1999 | $ 1.69B | $ 65M | $ 40M |
| 1998 | $ 1.61B | $ 68M | $ 22M |
| 1997 | $ 1.51B | -$ 106M | $ 23M |
| 1996 | $ 1.60B | -$ 153M | $ 29M |
| 1995 | $ 1.43B | -$ 12M | $ 16M |
| 1994 | $ 872M | $ 30M | $ 26M |
| 1993 | $ 760M | $ 112M | $ 12M |
| 1992 | $ 721M | $ 40M | $ 33M |
| 1991 | $ 603M | $ 103M | $ 51M |
| IPO1990 | $ 501M | $ 82M | $ 45M |

Laboratory Corporation of America Holdings fundamental performance
Between 2005 and 2025, revenue grew from $ 3.32B to $ 13.95B and net income grew from $ 386M to $ 876M. Revenue increased in 18 of those 20 years; net income in 11.
Across Laboratory Corporation of America Holdings's full reported history, from 1990 to 2025, revenue grew from $ 501M to $ 13.95B and net income grew from $ 82M to $ 876M. Revenue increased in 92% of the years measured; net income in 61%.
Laboratory Corporation of America Holdings currently holds a 20-year HDB Score of 6.0 out of 10. How the HDB Score is calculated.
Membership
Continue LH’s history
The public Archive runs through 2021. Membership adds recent and current rankings.
- Recent and current rankings across 5,187 companies
- Compare companies with the latest data
- Track your research shortlist in a portfolio
Explore other companies
Corcept Therapeutics IncorporatedCORT· revenue grew in 89% of years
Bio-Rad Laboratories IncBIO· revenue grew in 75% of years
Healthcare Services Group IncHCSG· revenue grew in 80% of years
McKesson CorporationMCK· revenue grew in 95% of years
Tenet Healthcare CorporationTHC· revenue grew in 70% of years